Traumatic brain injury biomarker shows promise to support rapid damage evaluation and predict outcomes

July 16, 2018

Philadelphia, July 16, 2018 - A new study in The American Journal of Pathology found that a brain lipid molecule, lysophosphatidic acid (LPA), was significantly increased after traumatic brain injury (TBI) in a preclinical animal model. They also found that it was elevated in areas associated with cell death and axonal injury, both major hallmarks of moderate and severe TBI. This strengthens the evidence that LPA could be used as a biomarker of TBI through blood testing, potentially providing a prognostic indicator of injury and outcome.

TBI is characterized by impairments in cognition, emotion, or physical function caused by a violent blow to the head or direct brain penetration by an object. Upon injury, it is often difficult to evaluate the extent of damage or predict how long the impairment will last or whether it will worsen.

"TBI affects nearly 1.7 million individuals each year. There is a need for non-invasive biomarkers to indicate the degree of injury, predict functional outcomes, and advise how long an injured patient must remain away from sports or work before resuming any activity," explained lead investigator Neil G. Harris, PhD, of the Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. "LPA may well be a potential marker for that since we found it to be associated with major regions of brain pathology. It is also present in blood in high concentrations after injury."

Although LPA has been previously suggested as a marker for TBI, this study showed for the first time that levels of LPA change within the area of the injury as well as in regions distant to the injury site and linked these changes to pathological findings in brain cells. Investigators used matrix-assisted laser desorption ionization imaging mass spectrometry (MALDI IMS). This sophisticated technology allowed them to measure fine changes in lipid distribution within brain slices. They linked MALDI IMS findings to cellular pathology, such as axonal injury or cell death, using immunohistochemical (IHC) techniques.

Strong enhancement in LPA and some of its metabolites was seen throughout the brain beginning one hour after compression brain injury. By three hours after injury, high levels of LPA were noted in the cerebellum, corpus callosum, hippocampus, and other areas. "These observations demonstrate that acute injury profoundly alters LPA and LPA metabolite expression throughout the brain, and that this occurs especially in white matter regions at both near and far sites from the injury epicenter," commented lead author Whitney S. McDonald, PhD, of the Brain Injury Research Center, Department of Neurosurgery and Brain Research Center, UCLA, Los Angeles, CA, USA.

Atrophy of the connections between the cortex and thalamus is a common finding in TBI. When the investigators analyzed the thalamus in this animal model, they found intracellular levels of LPA and its precursor phosphatidic acid increased one hour after injury but returned to normal levels three hours after injury. A special stain revealed that cell death was evident after three hours, leading the researchers to suggest that the observed changes in lipid levels are part of the early response of the brain to trauma and act to initiate the later sequence of neurodegenerative changes associated with TBI. The researchers also saw that although LPA levels were elevated in hemorrhagic areas, increases were also seen in brain regions not contaminated with blood.

"These data show that LPA may be a useful biomarker of cellular pathology after TBI," said Dr. Harris. He noted that other investigators have reported that LPA is significantly increased within 24 to 36 hours in some patients with severe TBI, and elevated levels of LPA metabolites were associated with poor patient outcomes. "If LPA can be shown to be a good predictor of outcome, then measuring LPA blood levels has potential as a prognostic indicator of injury and outcome."

LPA is a simple phospholipid involved in many biological functions such as the regulation of cellular proliferation, migration, differentiation, and suppression of cell death. LPA and its receptors are found throughout the nervous system. The rapid onset of pathology and the complexity of the cellular response to TBI suggest that these act as early signaling messengers involved in initiating the cascade of cellular events that promote functional impairment after trauma. LPA has been shown to be significantly involved in the pathology of central nervous system injury.


Related Traumatic Brain Injury Articles from Brightsurf:

Point-of-care biomarker assay for traumatic brain injury
Intracranial abnormalities on CT scan in patients with traumatic brain injury (TBI) can be predicted by glial fibrillary acidic protein (GFAP) levels in the blood.

Long-studied protein could be a measure of traumatic brain injury
WRAIR scientists have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for TBI.

Reducing dangerous swelling in traumatic brain injury
After a traumatic brain injury (TBI), the most harmful damage is caused by secondary swelling of the brain compressed inside the skull.

Blue light can help heal mild traumatic brain injury
Daily exposure to blue wavelength light each morning helps to re-entrain the circadian rhythm so that people get better, more regular sleep which was translated into improvements in cognitive function, reduced daytime sleepiness and actual brain repair.

Dealing a therapeutic counterblow to traumatic brain injury
A team of NJIT biomedical engineers are developing a therapy which shows early indications it can protect neurons and stimulate the regrowth of blood vessels in damaged tissue.

Predictors of cognitive recovery following mild to severe traumatic brain injury
Researchers have shown that higher intelligence and younger age are predictors of greater cognitive recovery 2-5 years post-mild to severe traumatic brain injury (TBI).

Which car crashes cause traumatic brain injury?
Motor vehicle crashes are one of the most common causes of TBI-related emergency room visits, hospitalizations and deaths.

Traumatic brain injury and kids: New treatment guidelines issued
To help promote the highest standards of care, and improve the overall rates of survival and recovery following TBI, a panel of pediatric critical care, neurosurgery and other pediatric experts today issued the third edition of the Brain Trauma Foundation Guidelines for the Management of Pediatric Severe TBI.

Addressing sleep disorders after traumatic brain injury
Amsterdam, NL, December 10, 2018 - Disorders of sleep are some of the most common problems experienced by patients after traumatic brain injury (TBI).

Rutgers researchers discover possible cause for Alzheimer's and traumatic brain injury
Rutgers researchers discover a possible cause for Alzheimer's and traumatic brain injury, and the new mechanism may have also led to the discovery of an effective treatment.

Read More: Traumatic Brain Injury News and Traumatic Brain Injury Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to